Siberia | Technology & innovation

New glaucoma therapy comes from Siberia

22 Jan '18
A scientific team in Novosibirsk, in Siberia, has developed what it claims is the worlds first degradable bioimplant to fight glaucoma.

According to the World Health Organization, glaucoma is the most widespread cause of blindness. The disease manifests itself through slowly progressing degeneration of the optic nerve, a typical consequence of chronic ocular hypertension when the optic nerve fails to transmit visual information from the retina to the brain, thus causing an irretrievable loss of visual perception.

The researchers at the Novosibirsk branch of the Academician Fyodorov Eye Microsurgery Center partnered with Vertikal, a local high-tech company, to develop what branch CEO Valery Chernykh referred to as the worlds first biodegradable microprosthetic device, an implant to treat glaucoma.

Using our prosthesis will help patients preserve their eyesight, Mr. Chernykh added with confidence.

The current glaucoma therapy calls for the creation of surgically induced drainage to lower intraocular pressure (IOP) by draining intraocular fluid. Within five years of surgery, tissue grows over the implant that is almost solely used for this surgery in Russia, thus occluding the pouring of the fluid. That renders nearly 30% of such medical operations ineffective, and necessitates recurrent surgery every five years.

The new solution offers biodegradable drainage consisting of caprolactan, an artificial polymer, and collagen, a natural polymer with properties biocompatible with the eye tissue, which degrades biologically within four months.

By the end of this period the patients body will have used the prosthesis to grow natural and unobstructable intraocular fluid drain. The implant insertion surgery costs $260-340, depending on complexity, versus double or triple that with the imported implant used, Mr. Chernykh said.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations: Novosibirsk

Tags: ocular hypertension (0) / glaucoma (0) / degradable bioimplant (0) /

Latest News: Siberia
22 Jan '18 | Technology & innovation
10 Jan '18 | Energy, utilities | Materials, extraction
22 Dec '17 | Energy, utilities | Technology & innovation
6 Dec '17 | Materials, extraction | Finance, business
10 Nov '17 | Technology & innovation | Energy, utilities
 

Feature stories

21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
26 Jul '17
Scientists at Tomsk Polytechnic (TPU) in Siberia have...
Search (News archive - 21210)
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

16 Feb '18
Hemopharm, a Russian biotech company, is developing a...
14 Feb '18
Moscow scientists are offering their own technology...
13 Feb '18
Super-hard and durable glass ceramics has been...

Most read stories from last week

16 Feb '18
Hemopharm, a Russian biotech company, is developing a...